Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05093413 · ClinicalTrials.gov registry record · NA

Olfactory Decision-making and Deprived Sleep

A NA study of Sleep Deprivation, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
46
Enrollment target
1
Study location

NCT05093413: Completed NA study of Sleep Deprivation, sponsored by Northwestern University.

NCT05093413 is a NA study of Sleep Deprivation that has completed, run by Northwestern University. The registered enrollment target is 46 participants, below the 90-participant average among 34 other Sleep Deprivation trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05093413, a NA study of Sleep Deprivation, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
46 participants
Enrollment target
1
Study location

Study Summary

This research study will use magnetic resonance imaging (MRI) and olfactory stimuli to better understand the connection between sleep deprivation, brain activity, and olfaction in humans.

Primary Outcome

Food-like perceptual responses to binary food-nonfood odor mixtures

Conditions Studied

Interventions

  • BEHAVIORAL Sleep deprivation

Study Locations (1)

Illinois

  • Northwestern University - Chicago

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2021-01-14
Est. Completion 2022-05-19
Phase NA
Northwestern University

1,209 total trials

What the finished NCT05093413 record still lists

NCT05093413 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 90-participant average among 34 other Sleep Deprivation trials with a reported enrollment target (49% lower).

The record links to 1 condition, with Sleep Deprivation appearing as the primary indexed condition, and to 1 intervention - of which Sleep deprivation is the first listed.

NCT05093413 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT05093413 about?

NCT05093413 is a clinical study titled "Olfactory Decision-making and Deprived Sleep". This research study will use magnetic resonance imaging (MRI) and olfactory stimuli to better understand the connection between sleep deprivation, brain activity, and olfaction in humans.

What is the current status of trial NCT05093413?

This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2021-01-14. Estimated completion is 2022-05-19.

What conditions does trial NCT05093413 study?

This clinical trial studies the following conditions: Sleep Deprivation.

What interventions are being tested in trial NCT05093413?

The interventions under investigation include: Sleep deprivation (BEHAVIORAL).

Who is sponsoring clinical trial NCT05093413?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05093413 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep Deprivation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05093413's enrollment target sits among peer trials

46 22nd of 34 higher than 12 of 34 other Sleep Deprivation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sleep Deprivation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01890590 · 46 participants · NA

    A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

  • NCT03191149 · 46 participants · Phase 2

    Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • NCT03510208 · 46 participants · Phase 1

    Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

  • NCT04048278 · 46 participants · Early Phase 1

    Lidocaine Infusion in Pancreatic Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05093413, the US trial registry maintained by the National Library of Medicine. NCT05093413 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.